Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Results of IDA-FLAG programme in the treatment of recurrent acute myeloblastic leukaemia--preliminary report.

Włodzimierz Łuczyński, Katarzyna Muszyńska-Rosłan, Maryna Krawczuk-Rybak, Marta Kuźmicz, Anna Iwaszkiewicz-Pawłowska, Jacek Kaliszewski

Med Sci Monit 2001; 7(1): CR125-129 :: ID: 421175

Abstract

BACKGROUND: Unsatisfactory treatment results of acute myeloblastic leukaemiainspire the search for new drugs, characterised by higher efficiency and lower toxicity. The aim of thestudy was the assessment of the efficiency and side effects associated with the implementation of IDA-FLAGprotocol.
MATERIAL AND METHODS: The assessment of treatment results and undesirable effects was basedon the material of 4 children with the relapse of acute myeloblastic leukaemia, after a total of 6 IDA-FLAGprotocols.
RESULTS: Complete remission was obtained in 2 (50%) children, with mean remission time of13.5 months. One of the children underwent the transplantation of haematopoietic cells from unrelateddonor. The main side effect observed was bone marrow aplasia. Leucopenia, granulocytopenia, thrombocytopeniaand anaemia persisted for approx. 20 days. Apart from haematological symptoms, the following were alsoobserved: the symptoms of intolerance after ARA-C, aspergillosis of paranasal sinuses and lungs and severecoagulation disorders.
CONCLUSION: IDA-FLAG protocol may be recommended for use in children with AMLrelapse and the undesirable effects observed are acceptable.

Keywords: acute myeloblastic leukaemia, children, fludarabine, IDA-FLAG

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750